IGC PHARMA INC (IGC)

US45408X3089 - Common Stock

0.439  -0.02 (-3.85%)

Premarket: 0.419 -0.02 (-4.56%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
1.22M910.00K400.00K900.00K4.07M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
591.00K470.00K200.00K790.00K3.96M
Gross Profit
623.00K440.00K190.00K110.00K120.00K
Operating Expenses
11.17M11.63M10.87M8.83M6.98M
Research and Development
3.41M3.46M2.33M930.00K1.01M
Selling, General, and Administrative Expenses
7.75M8.18M8.07M7.91M5.97M
Operating Income
-10.54M-11.19M-10.68M-8.72M-6.87M
Interest Income/Expense
N/AN/A-1.70MN/AN/A
Other Income/Expense
102.00K70.00K460.00K80.00K330.00K
Non Recurring Items
-3.75M-380.00K-3.10M-170.00K-780.00K
Income Before Taxes
-14.15M-11.51M-15.02M-8.81M-7.32M
Income Tax
N/A0.000.000.000.00
Net Income
-14.15M-11.51M-15.02M-8.81M-7.32M
EBITDA
-9.91M-10.53M-10.03M-8.24M-6.73M
 
Per Share Data
EPS Diluted Total Ops
-0.26-0.22-0.30-0.21-0.19
 
Statistics
Gross Profit Margin
50.90%48.35%47.50%12.22%2.95%
Profit Margin
-1155.96%-1264.84%-3755.00%-978.89%-179.85%
Operating Profit Margin
-861.52%-1229.67%-2670.00%-968.89%-168.80%

All data in USD

Charts